# FDA Inspection 1294906 - Bloodworks - December 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/60f2f626-df69-4b58-b132-eb7e90c6e19e
Source feed: FDA_Inspections

> FDA Inspection 1294906 for Bloodworks on December 11, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1294906
- Company Name: Bloodworks
- Inspection Date: 2025-12-11
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Seattle District Office

## Related Documents

- [FDA Inspection 1294906 - 2025-12-11](https://www.keypedia.com/records/fda_inspections/bloodworks/434763ad-6025-46be-a3e0-aafe9ee382fa)
- [FDA Inspection 1238690 - 2024-05-03](https://www.keypedia.com/records/fda_inspections/bloodworks/c6717275-d4f5-4c45-adc7-b32b8f50196e)
- [FDA Inspection 1238690 - 2024-05-03](https://www.keypedia.com/records/fda_inspections/bloodworks/b191869c-417a-4ed5-93d8-978f07e4d82c)
- [FDA Inspection 1146276 - 2021-07-16](https://www.keypedia.com/records/fda_inspections/bloodworks/8dc2aa57-956c-4777-8bbb-5585b6b5f86a)
- [FDA Inspection 1146276 - 2021-07-16](https://www.keypedia.com/records/fda_inspections/bloodworks/f1a682de-1430-4176-b963-421ddae4efda)

Company: https://www.keypedia.com/companies/bloodworks/7ecb0a9c-b4a3-41bb-8c61-3be1042e3e8e

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913